Holding in Company
September 01 2000 - 5:03AM
UK Regulatory
RNS Number:1630Q
Cambridge Antibody Tech Group PLC
30 August 2000
NOTIFICATIONS UNDER SECTIONS 198 TO 202 -- UK COMPANIES ACT
1. Company in which shares are held: CAMBRIDGE ANTIBODY TECH GROUP PLC
2. Notifiable Interest: ORDINARY SHARES
A FMR Corp
82 Devonshire Street
Boston, MA 02109
Parent holding company of Fidelity Management & Research Company
(FMRCO), investment manager for US mutual funds, and Fidelity
Management Trust Company (FMTC), a US state chartered bank which
acts as trustee or investment manager of various pension and trust
accounts. (See Schedule A for listing of Registered Shareholders
and their holdings.)
B Fidelity International Limited (FIL)
P.O. BOX HM 670
Hamilton HMCX, Bermuda
Parent holding company for various direct and indirect subsidiaries,
including Fidelity Investment Services Ltd. (FISL) and Fidelity
Pension Management (FPM), investment managers for various non-US
investment companies and institutional clients. (See Schedule A for
listing of Registered Shareholders and their holdings).
3. The notifiable interests also comprise the notifiable interest of
Mr Edward C Johnson 3d
82 Devonshire Street
Boston, MA 02109
A principal shareholder of FMR Corp. and Fidelity International
Limited.
4. The notifiable interests include interest held on behalf of authorized
unit trust schemes in the U.K. notwithstanding the exemption from
reporting pursuant to Section 209 (1) (e) of the Companies Act 1985.
5. These notifications of disclosable interests constitute separate
notifications of interest in the shares and are combined solely for
the purposes of clarity. Nothing herein should be taken to indicate
that FMR Corp. and its direct and indirect subsidiaries,
Fidelity International Limited and its direct and indirect subsidiaries
or Mr Edward C Johnson 3d act as a group or in concert in respect of
the disclosed interests, or that they are required to submit these
notifications on a joint basis.
6. The disclosable interests arise under section 208(4) (b) of the Act,
namely where a person, not being the registered holder, is entitled
to exercise a right conferred by the holding of the shares or to
control the exercise of such rights, or under section 203 of the Act
respectively.
SCHEDULE A
SECURITY: Cambridge Antibody Tech Group Plc
SHARES HELD MANAGEMENT NOMINEE/REGISTERED
COMPANY NAME
(Ordinary Shares)
684,055 FMRCO CHASE NOMINEES LIMITED
83,800 FMRCO STATE STREET NOMINEES LIMITED
680,296 FMRCO LLOYDS BANK NOMINEES LIMITED
4,482 FIL
TOTAL ORDINARY SHARES: 1,452,633
CURRENT OWNERSHIP PERCENTAGE: 4.21%
SHARES IN ISSUE: 34,530,994
CHANGE IN HOLDINGS SINCE
LAST FILING: +406,871 ORDINARY SHARES 1.18%
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024